𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis and preliminary evaluation of [11C]KF17837, a selective adenosine A2A antagonist

✍ Scribed by Kiichi Ishiwata; Junko Noguchi; Hinako Toyama; Yojiro Sakiyama; Nobuaki Koike; Shin-Ichi Ishii; Keiichi Oda; Kazutoyo Endo; Fumio Suzuki; Michio Senda


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
371 KB
Volume
47
Category
Article
ISSN
0969-8043

No coin nor oath required. For personal study only.

✦ Synopsis


An 11C-labeled selective adenosine A2A antagonist, (E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-[11C]-methylxanthine ([11C]KF17837), was prepared by reaction of (E)-8-(3,4-dimethoxystyryl)-1,3-dipropylxanthine and [11C]methyl iodide with decay-corrected radiochemical yield of 19-50%, radiochemical purity of > 99%, sp. act. of 17-100 GBq/mumol and preparation time of 20-25 min. In mice, the myocardium showed the highest (13.4% ID/g) at 5 min after i.v. injection, which decreased gradually with time. The specific myocardial uptake was visualized by gamma-camera. In the brain region the radioactivity level was higher in the A2A receptors-rich striatum than in the cortex and cerebellum. The specific striatal uptake in rats was clearly demonstrated by PET. These results have shown that [11C]KF17837 is a potential PET radioligand for mapping the adenosine A2A receptors in the heart and brain.


πŸ“œ SIMILAR VOLUMES


Synthesis and evaluation of [11C]RU40555
✍ Takahiro Matsuya; Hiroyuki Takamatsu; Yoshihiro Murakami; Akihiro Noda; Kazuhiko πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 224 KB

## Abstract We demonstrated the synthesis of carbon‐11 labeled 17‐__Ξ±__‐hydroxy‐11‐__Ξ²__‐/4‐/[methyl]‐[1‐methylethyl]‐aminophenyl/‐17__Ξ±__‐[prop‐1‐ynyl]esta‐4‐9‐diene‐3‐one (RU40555), a selective glucocorticoid receptor (GR) antagonist, and examined the __in vivo__ profile of [^11^C]RU40555. [^11^

Synthesis and evaluation of 1,2,4-triazo
✍ Bidhan A. Shinkre; T. Santhosh Kumar; Zhan-Guo Gao; Francesca Deflorian; Kenneth πŸ“‚ Article πŸ“… 2010 πŸ› Elsevier Science 🌐 English βš– 645 KB

Movement disorders such as Parkinson's disease and Huntington's disease are serious life-limiting and debilitating movement disorders. Their onset typically occurs from mid-life to late in life, and effective diagnostic techniques for detecting and following the disease course are lacking. Our goal